WO2025229401 - SYSTEMS AND METHODS FOR SCREENING OF BIOLOGICAL COMPONENTS

National phase entry is expected:
Publication Number WO/2025/229401
Publication Date 06.11.2025
International Application No. PCT/IB2025/000197
International Filing Date 02.05.2025
Title **
[English] SYSTEMS AND METHODS FOR SCREENING OF BIOLOGICAL COMPONENTS
[French] SYSTÈMES ET PROCÉDÉS DE CRIBLAGE DE COMPOSANTS BIOLOGIQUES
Applicants **
CELLANOME, INC.
Inventors
ZARGARI -PARISET, Eloise
BOSTICK, Magnolia Louise
BETTS, Craig
MORADI, Patriss
KHURANA, Tarun Kumar
Priority Data
FR2404680   03.05.2024   FR
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3656
EPO Filing, Examination, Granting33985
Japan Filing, Examination, Granting3388
South Korea Filing, Examination, Granting4572
USA Filing, Examination, Granting11740
MasterCard Visa
Total: 57,341
Contact Us
Abstract[English] Described herein are methods and systems for utilizing the formation and degradation of hydrogel chambers to analyze biological components comprising guide RNA barcodes associated with one or more genetic modifications. A method for analyzing a biological component can include introducing the biological component into a fluidic device; in the fluidic device, encapsulating the biological component in a hydrogel chamber, wherein the biological component comprises a guide ribonucleic acid (RNA) molecule associated with a genetic modification of the biological component; and releasing the guide RNA molecule from the biological component.[French] L'invention concerne des procédés et des systèmes permettant d'utiliser la formation et la dégradation de chambres d'hydrogel pour analyser des composants biologiques comprenant des codes-barres d'ARN guide associés à une ou plusieurs modifications génétiques. Un procédé d'analyse d'un composant biologique peut consister à : introduire le composant biologique dans un dispositif fluidique ; dans le dispositif fluidique, encapsuler le composant biologique dans une chambre d'hydrogel, le composant biologique comprenant une molécule d'acide ribonucléique (ARN) guide associée à une modification génétique du composant biologique ; et libérer la molécule d'ARN guide du composant biologique.